CIK 0000876343 · Non-accelerated filer<br>Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 943127919
- Phone
- 5105213390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-31 | Culley Brian M President and CEO | Option exercise | +15,450 | 81,373 | ||
| 2021-12-31 | Culley Brian M President and CEO | Shares withheld for taxes | −5,343 | $2.45 | $13K | 76,030 |
| 2021-12-31 | Culley Brian M President and CEO | Option exercise · Restricted Stock Units | −15,450 | 30,900 | ||
| 2021-12-29 | Hogge Gary S. SVP,Clinical & Medical Affairs | Option exercise | +9,250 | $0.69 | $6K | 37,695 |
| 2021-12-29 | Hogge Gary S. SVP,Clinical & Medical Affairs | Sale | −9,250 | $2.49 | $23K | 28,445 |
| 2021-12-29 | Hogge Gary S. SVP,Clinical & Medical Affairs | Sale | −28,445 | $2.44 | $69K | 0 |
| 2021-12-29 | Hogge Gary S. SVP,Clinical & Medical Affairs | Option exercise · Employee Stock Option (right to buy) | −9,250 | 249,750 | ||
| 2021-12-28 | Hogge Gary S. SVP,Clinical & Medical Affairs | Option exercise | +185,000 | $0.69 | $128K | 213,445 |
| 2021-12-28 | Hogge Gary S. SVP,Clinical & Medical Affairs | Option exercise | +236,899 | $2.11 | $500K | 450,344 |
| 2021-12-28 | Hogge Gary S. SVP,Clinical & Medical Affairs | Option exercise | +79,689 | $1.14 | $91K | 530,033 |
| 2021-12-28 | Hogge Gary S. SVP,Clinical & Medical Affairs | Sale | −501,588 | $2.45 | $1.2M | 28,445 |
| 2021-12-28 | Hogge Gary S. SVP,Clinical & Medical Affairs | Option exercise · Employee Stock Option (right to buy) | −185,000 | 259,000 | ||
| 2021-12-28 | Hogge Gary S. SVP,Clinical & Medical Affairs | Option exercise · Employee Stock Option (right to buy) | −236,899 | 10,301 | ||
| 2021-12-28 | Hogge Gary S. SVP,Clinical & Medical Affairs | Option exercise · Employee Stock Option (right to buy) | −79,689 | 32,811 | ||
| 2021-09-30 | Culley Brian M President and CEO | Option exercise | +15,450 | 71,266 | ||
| 2021-09-30 | Culley Brian M President and CEO | Shares withheld for taxes | −5,343 | $2.52 | $13K | 65,923 |
| 2021-09-30 | Culley Brian M President and CEO | Option exercise · Restricted Stock Units | −15,450 | 46,350 | ||
| 2021-09-01 | Samuel George A. III General Counsel/Secretary | Grant or award · Employee Stock Option (right to buy) | +695,000 | 695,000 | ||
| 2021-07-01 | BAILEY DON M Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2021-07-01 | ANDREWS DEBORAH J Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 |
Page 7 of 8 · 153 trades